Allspring Global Investments’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-73
Closed -$1.22K 2250
2024
Q3
$1.22K Sell
73
-1,662
-96% -$35.7K ﹤0.01% 2314
2024
Q2
$35.8K Sell
1,735
-389
-18% -$8.42K ﹤0.01% 2014
2024
Q1
$52.6K Buy
2,124
+177
+9% +$5.27K ﹤0.01% 1939
2023
Q4
$70.8K Sell
1,947
-1,149
-37% -$44.2K ﹤0.01% 1845
2023
Q3
$149K Buy
3,096
+1,140
+58% +$67.7K ﹤0.01% 1845
2023
Q2
$134K Sell
1,956
-3,070
-61% -$198K ﹤0.01% 1953
2023
Q1
$244K Sell
5,026
-1,958
-28% -$103K ﹤0.01% 1770
2022
Q4
$421K Sell
6,984
-5,773
-45% -$338K ﹤0.01% 1647
2022
Q3
$773K Sell
12,757
-351
-3% -$11.1K ﹤0.01% 1485
2022
Q2
$355K Sell
13,108
-12,691
-49% -$371K ﹤0.01% 1664
2022
Q1
$943K Sell
25,799
-71,533
-73% -$2.58M ﹤0.01% 1912
2021
Q4
$4.81M Buy
+97,332
New +$5.4M 0.01% 1184

Other funds holding PRTA

Allspring Global Investments's PRTA Position: Q4 2024 in Review

Allspring Global Investments sold out of Prothena Corp (PRTA) in Q4 2024, closing a stake of 73 shares — an estimated $1.22K sold.

Allspring Global Investments first reported a position in PRTA in Q4 2021 and held it in 12 quarters. The position peaked at $4.81M in Q4 2021. 170 funds tracked by Wall St. Rank hold PRTA as of Q4 2024.

  • Allspring Global Investments reported no remaining Prothena Corp position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 73 Prothena Corp shares in Q4 2024, an estimated $1.22K.
  • Allspring Global Investments first reported a position in Prothena Corp in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Prothena Corp position peaked at $4.81M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.